1. Emerging Treatment Paradigms to Improve Quality of Life in Behçet Syndrome

2. Behçet Syndrome (BS) Overview

3. Prevalence of BS

4. Demographics of BS

5. Pathergy

6. Etiology of BS

7. Mucocutaneous Manifestations of BS

8. Skin Lesions

9. Genital Lesions

10. Oral Ulcers

11. Oral Ulcers (cont)

12. Differential Diagnosis Lichen Planus

13. Ocular Manifestations in BS

14. Other Manifestations in BS

15. Other Manifestations in BS (cont)

16. Diagnosing BS

17. ISG Criteria

18. Revised ICBD Criteria

19. Overview of Treatments for BS

20. 2018 EULAR Recommendations in BS Overarching Principles

21. Colchicine

22. Topical Therapies for Oral Ulcers in BS

23. Apremilast for Treatment of Oral Ulcers in BS Randomized Phase 2 Study

24. Apremilast for Treatment of Oral Ulcers in BS Phase 2 Study Results

25. Apremilast for Treatment of Oral Ulcers in BS Randomized Phase 3 Study

26. Apremilast for Treatment of Oral Ulcers in BS Phase 3 Study Results

27. Apremilast for Refractory Oral/Genital Ulcers Open-Label Study

28. Etanercept for Treatment of Oral Ulcers in BS

29. 2018 EULAR Recommendations for Ocular Disease in BS

30. Anti-TNF Agents in Ocular Disease in BS

31. IL Inhibitors

32. Concluding Remarks

33. Abbreviations